Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04764721
NA

Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Subjects With a History of Severe COVID-19

Sponsor: Central Hospital, Nancy, France

View on ClinicalTrials.gov

Summary

Patients with Covid-19 (Coronavirus disease 19) may experience multiple neurological symptoms . 18F-FDG PET-CT ( Positons EmissionTomography coupled with a Computer Tomography with flurodesoxyglucose labelled with fluor 18), which reflects neuronal glycolytic metabolism, shows early variations in neuronal function. Moreover the tropism of Covid-19 is essentially pulmonary and the hypothesis of this study is with 18F-FDG PET-CT it's possible to study the relationship between cerebral metabolism and the metabolism of pulmonary lesions following Covid-19 infection.

Official title: Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Young Subjects With Sequelae Psycho-cognitive Disorders in the Aftermath of Severe Covid-19

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

25

Start Date

2021-11-17

Completion Date

2023-11-27

Last Updated

2026-06-25

Healthy Volunteers

No

Conditions

Interventions

DEVICE

18F-FDG PET-CT

Enrolled patients in Neurocog-Covid will receive a 18F-FDG PET-CT

Locations (1)

CHRU NANCY Brabois, nuclear medicine department

Vandœuvre-lès-Nancy, France